TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/31/2024
Back to search
Official data from USPTO
HEMA BIOLOGICS CARES
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
HEMA BIOLOGICS CARES
ST13
US500000090469222Class
36, 44, 45
Filing
90469222
Registration
6913843
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
25
Latest update
05/31/2024
Trademark type
Word
Nice classes
36, 44, 45
Filing date
01/15/2021
Registration date
11/29/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/29/2022
Last transaction
05/31/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
01/04/2021
First use in commerce
01/04/2021
Drawing code
4
Owner type
16
Owner location
Louisville, KY
Examiner
LEASER, ANDREW
Law office
M80
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Hema Biologics, LLC
Representatives
Amy B. Berge Gray Ice Higdon, PLLC
Technical classification
Nice Classes
Class 36Class 44Class 45
Vienna Codes
No Vienna codes available.
Goods and services
Class 36
Charitable servicespatient assistance programs which provide help to patients that do not have prescription drug coverage or who have difficulty paying their prescription drug expenses by reimbursing patients for out-of-pocket expenses such as prescription co-pays; providing consulting in the field of patients' healthcare insurance benefits
Class 44
Charitable servicespatient assistance program to provide drugs free of charge to low-income patients without prescription drug coverage; providing medical information regarding patients' prescription drugs and drug therapy; providing consultation in the dispensing of pharmaceuticals for persons with chronic health issues
Class 45
Providing patient advocate and case management servicescoordinating the procurement and administration of medication; providing information about legal eligibility requirements for government medical and pharmaceutical programs
Publications
History of USPTO decisions and trademark events.
25 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/31/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/31/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/29/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
11/29/2022
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
10/27/2022
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
10/26/2022
SUPC
STATEMENT OF USE PROCESSING COMPLETE
10/07/2022
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
10/06/2022
IUAF
USE AMENDMENT FILED
09/23/2022
EISU
TEAS STATEMENT OF USE RECEIVED
09/23/2022
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
05/03/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/08/2022
PUBO
PUBLISHED FOR OPPOSITION
03/08/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/16/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/03/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/03/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/02/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/02/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/03/2021
GNRT
NON-FINAL ACTION E-MAILED
08/03/2021
CNRT
NON-FINAL ACTION WRITTEN
08/03/2021
DOCK
ASSIGNED TO EXAMINER
07/27/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/16/2021
NWAP
NEW APPLICATION ENTERED
01/19/2021
Continuous trademark protection
Get notified about every new filing that threatens HEMA BIOLOGICS CARES or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.